Finance

Lists
ORKA:NASDAQ
Oruka Therapeutics Inc
US$ १०५.३५
+०.३४%
(+०.३६) 1D
US$ १०५.३५
०.००% (०.००)
After hours
Closed: नोभेम्बर १३, १६:००:०० GMT-५  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ORKA...
Open
US$ १०४.२८
High
US$ १०६.८७
Low
US$ १०१.५६
Mkt. cap
७.१५ अरब
Avg. vol.
९.७३ लाख
Volume
६.८० लाख
52-wk high
US$ ११५.५२
52-wk low
US$ २५.२३
EPS
-US$ २.४७
Beta
-०.३८
Shares outstanding
६.७८ करोड
No. of employees
६८
Open
US$ १०४.२८
High
US$ १०६.८७
Low
US$ १०१.५६
Mkt. cap
७.१५ अरब
Avg. vol.
९.७३ लाख
Volume
६.८० लाख
52-wk high
US$ ११५.५२
52-wk low
US$ २५.२३
EPS
-US$ २.४७
Beta
-०.३८
Shares outstanding
६.७८ करोड
No. of employees
६८
News stories
From web sources and news partners
Investing.com Canada
Investing.com Canada
·
४ घण्टा पहिले
Oruka Therapeutics director Kristine Ball sells $1.89M stock By Investing.com
Investing.com Nigeria
Investing.com Nigeria
·
४ घण्टा पहिले
Oruka Therapeutics SVP sells $1.05M in shares By Investing.com
About Oruka Therapeutics Inc
CEO-
Employees६८
Founded२०२४
HeadquartersWestminster, कोलोराडो, संयुक्त राज्य अमेरिका
SectorHealth Care
Industry-
Analyst ratings
Based on 12 analysts giving stock ratings to ORKA in the past 3 months
Strong buy
Buy
12
Hold
0
Sell
0
12-month forecast
Based on 12 Wall Street analysts offering 12 month price targets for ORKA in the last 3 months.
Highest
Current US$ १०५.३५
US$ २००.०० (+८९.८४%)
Average
US$ १५३.६० (+४५.८०%)
Lowest
US$ १०५.०० (-०.३३%)
Analyst
Recommendation
Action
Price target
Projected
Date
Michael Yee
UBS
Buy
Maintained
US$ १३०.००
+२३.४%
11/10/2026
Yasmeen Rahimi
Piper Sandler
Buy
Maintained
US$ १८०.००
+७०.९%
11/10/2026
Unknown Analyst
Guggenheim
Buy
Reiterated
US$ २००.००
+८९.८%
11/09/2026
Alex Thompson CFA
Stifel Nicolaus
Buy
Reiterated
US$ १५०.००
+४२.४%
11/10/2026
Mitchell Kapoor
H.C. Wainwright
Buy
Reiterated
US$ १२०.००
+१३.९%
11/10/2026
Julian Harrison
BTIG
Buy
Reiterated
US$ १५१.००
+४३.३%
11/09/2026
Etzer Darout
Barclays
Buy
Maintained
US$ १६०.००
+५१.९%
11/10/2026
David Risinger
Leerink Partners
Buy
Reiterated
-
-
10/27/2026
Martin Fan
Wedbush
Buy
Reiterated
US$ १६५.००
+५६.६%
10/27/2026
Unknown Analyst
Wedbush
Buy
Reiterated
US$ १६५.००
+५६.६%
10/27/2026
Kaveri Pohlman
Clear Street
Buy
Maintained
US$ १०५.००
-०.३%
10/26/2026
David Nierengarten
Wedbush
Buy
Maintained
US$ १६५.००
+५६.६%
09/24/2026
Sam Slutsky
LifeSci Capital
Buy
Maintained
US$ १७५.००
+६६.१%
09/23/2026
Tyler Van Buren
TD Cowen
Buy
Maintained
-
-
08/26/2026
Roger Song
Jefferies
Buy
Maintained
US$ १३३.००
+२६.२%
08/11/2026
Yatin Suneja
Guggenheim
Buy
Reiterated
US$ २००.००
+८९.८%
08/10/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
२०२६ सेप्टेम्बर
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
२.७६ करोड
२.९१ करोड
४.३३ करोड
५.३७ करोड
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
६७.९१ लाख
७२.८९ लाख
६८.५० लाख
८४.४० लाख
Operating expense
३.४४ करोड
३.६४ करोड
५.०१ करोड
६.२१ करोड
Total operating expenses
३.४४ करोड
३.६४ करोड
५.०१ करोड
६.२१ करोड
Operating income
-३.४४ करोड
-३.६४ करोड
-५.०१ करोड
-६.२१ करोड
Other non operating income
-१.०० हजार
८.०० हजार
४.०० हजार
५.०० हजार
EBT including unusual items
-२.९६ करोड
-३.१८ करोड
-४.१२ करोड
-५.०० करोड
EBT excluding unusual items
-२.९६ करोड
-३.१८ करोड
-४.१२ करोड
-५.०० करोड
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-२.९६ करोड
-३.१८ करोड
-४.१२ करोड
-५.०० करोड
Net profit margin
-
-
-
-
Earnings per share
-०.४५
-०.४८
-०.५५
-०.६३
Interest and investment income
४८.४९ लाख
४६.०६ लाख
८८.९७ लाख
१.२२ करोड
Interest expense
-
-
-
-
Net interest expenses
४८.४९ लाख
४६.०६ लाख
८८.९७ लाख
१.२२ करोड
Depreciation and amortization charges
-
-
-
-
EBITDA
-३.४४ करोड
-३.६४ करोड
-५.०१ करोड
-६.२१ करोड
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google एपहरू